ATE91078T1 - Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind. - Google Patents

Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.

Info

Publication number
ATE91078T1
ATE91078T1 AT89900211T AT89900211T ATE91078T1 AT E91078 T1 ATE91078 T1 AT E91078T1 AT 89900211 T AT89900211 T AT 89900211T AT 89900211 T AT89900211 T AT 89900211T AT E91078 T1 ATE91078 T1 AT E91078T1
Authority
AT
Austria
Prior art keywords
melatonin
derivatives
manufacture
effective against
against ageing
Prior art date
Application number
AT89900211T
Other languages
English (en)
Inventor
Walter Pierpaoli
Giorgio Maestroni
Original Assignee
Cell Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Eng Ag filed Critical Cell Eng Ag
Application granted granted Critical
Publication of ATE91078T1 publication Critical patent/ATE91078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
AT89900211T 1987-11-19 1988-11-21 Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind. ATE91078T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878727099A GB8727099D0 (en) 1987-11-19 1987-11-19 Compositions containing melantonin/homologues
EP89900211A EP0343223B1 (de) 1987-11-19 1988-11-21 Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind
PCT/EP1988/001059 WO1989004659A1 (en) 1987-11-19 1988-11-21 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging

Publications (1)

Publication Number Publication Date
ATE91078T1 true ATE91078T1 (de) 1993-07-15

Family

ID=10627216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89900211T ATE91078T1 (de) 1987-11-19 1988-11-21 Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.

Country Status (6)

Country Link
EP (1) EP0343223B1 (de)
JP (1) JP2568286B2 (de)
AT (1) ATE91078T1 (de)
DE (1) DE3882135T2 (de)
GB (1) GB8727099D0 (de)
WO (1) WO1989004659A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤
GB9000939D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa Improvement in the total synthesis of erbstatin analogs
GB9000950D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa New arylvinylamide derivatives and process for their preparation
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
IL105240A (en) * 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
FR2741802B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine pour traiter les peaux sensibles
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
WO1998005298A1 (es) * 1996-08-02 1998-02-12 Universidad De Granada Desarrollo de productos cosmeticos para uso humano a base de melatonina como producto activo
FR2753095B1 (fr) * 1996-09-06 1998-11-20 Oreal Utilisation de la melatonine comme agent anti-inflammatoire dans une composition cosmetique ou pharmaceutique
US5880116A (en) * 1996-12-13 1999-03-09 Neurocal International Use of celastrol to treat alzheimer's disease
WO2001009383A2 (en) * 1999-07-30 2001-02-08 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
AU2003273967A1 (en) 2003-10-03 2005-05-11 Veijlen N.V. Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
RU2361583C2 (ru) * 2003-10-03 2009-07-20 Вейлен Н.В. Применение соединений, способных повышать уровень igf-1 в сыворотке крови, при приготовлении терапевтической композиции для лечения стадий различных заболеваний, ассоциированных со снижением уровня igf-1 в сыворотке людей и животных
DE602004021010D1 (de) 2003-10-03 2009-06-18 Veijlen N V Tierfutterzusammensetzung
JP5973059B2 (ja) 2013-11-01 2016-08-23 スガツネ工業株式会社 ヒンジ装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642994A (en) * 1970-05-25 1972-02-15 Fernando Anton T Therapeutic process using melatonin
DE2435365A1 (de) * 1973-12-31 1976-01-29 Luigi Di Bella Pharmazeutisches mittel fuer die behandlung von allen leukaemieformen und neurotischen syndromen
EP0214254B1 (de) * 1985-03-04 1992-06-17 Cellena (Cell Engineering) A.G. Melatoninhaltige mittel sowie deren verwendungen

Also Published As

Publication number Publication date
DE3882135T2 (de) 1993-11-11
HK1007961A1 (en) 1999-04-30
JPH02502020A (ja) 1990-07-05
GB8727099D0 (en) 1987-12-23
JP2568286B2 (ja) 1996-12-25
WO1989004659A1 (en) 1989-06-01
DE3882135D1 (de) 1993-08-05
EP0343223A1 (de) 1989-11-29
EP0343223B1 (de) 1993-06-30

Similar Documents

Publication Publication Date Title
ATE91078T1 (de) Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.
ATE2620T1 (de) Polyhydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydro y-6-oxo-2h-pyran-2-yl)-aethyl)-1-naphthylenyl-2methylbutanoate, die entsprechenden hydroxysaeuren, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3787197D1 (de) Gerät zur Herstellung von Schichtpressstoffen.
IT1080233B (it) Processo per la produzione di materiali silicei
ATE63110T1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
NO20050063L (no) 2-heteroaryl karboksamider
ATA54881A (de) Kettengewirkte rohware zur herstellung von hoeschen
DE69005623D1 (de) Mikrobiologische herstellung von polyestern.
NO890046L (no) Disubstituerte pyridiner.
DE3785401D1 (de) Verwendung von phenylethanolaminen zur herstellung von arzneimitteln, wirksam fuer gastrointestinale beschwerden.
PT65749A (de) Verfahren zur herstellung von 1-(2-halogen-2-phenyl-athyl)-triazole und ihre verwendung als fungizide
AT352234B (de) Binde- bzw. klebemittel zur herstellung von holzprodukten
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
DE3851903D1 (de) Herstellung von Tabletten.
DE3876114D1 (de) Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten.
EP0144894A3 (de) Pharmazeutische Verwendung von substituierten O-Acyl-glycosiden
FI833770A7 (fi) Orgaanisia yhdisteitä ja niiden käyttö lääkkeinä.
ATE15894T1 (de) Heterocyclische derivate von amidoxinen, ihre herstellung und therapeutische verwendung.
BR8100539A (pt) Derivados de benzoxazolona,composicao fungicida ou bactericida contendo os mesmos,processo para sua preparacao bem como sua aplicacao
DE68914161D1 (de) Herstellung von prodrogen.
IT1078784B (it) Processo per la produzione di triazin 2.4 dioni nonche loro impiego come insetticidi
DE3869831D1 (de) Elektrolytische herstellung von chlordioxid.
CH548989A (de) Verfahren zur herstellung von formamidin-derivaten und deren verwendung als insektizide oder milbentoetende mittel.
IT7828215A0 (it) Procedimenti per la produzione dicomposti organici,in particolare tienobenzazepine e composizioni farmaceutiche relative
DE68922826D1 (de) Verwendung einer Zusammensetzung, die organisch gebundenes Germanium enthaltet, zur Herstellung von Arzneimitteln zur Behandlung von AIDS.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee